November 2012


In this Supplement

Evolving Thoracic Treatment

An Evidence-Based Approach.



Download a PDF of this supplement

Innovation Spotlight: Expanding Indications to Treat More Thoracic Patients

How a branch graft for the left subclavian artery may extend the benefits of endovascular repair.

By Frank R. Arko, III, MD

Single-Center IDE Experience Treating Acute Traumatic Aortic Transection

Single-center data demonstrating the utility and midterm stability of thoracic endografts for traumatic aortic transection.

By Rodney A. White, MD; Carlos E. Donayre, MD; Irwin Walot, MD; George Kopchok, BS; Ali Khoynezhad, MD, PhD, FACS, FACC

For International Audiences

The MOTHER Multicenter Registry

An overview and discussion of a registry that may help us understand how and to what degree various factors influence the risk of complications after TEVAR.

By Benjamin O. Patterson, BSc, MRCS, and Matt M. Thompson, MD, FRCS

For International Audiences

The Best Practice for Type B Aortic Dissection

Future refinements of stent graft technology, growing technical skill, and long-term outcome data are needed to determine the potential long-term benefit of endovascular repair.

By Rossella Fattori, MD; Lucia Marinucci, MD; Lucia Uguccioni, MD; Rosario Parisi, MD; and Gioel Gabrio Secco, MD

For International Audiences

Retrograde Type A Aortic Dissection

A review of the available literature on this rare but potentially catastrophic complication.

By Gabriele Piffaretti, MD, PhD; Santi Trimarchi, MD, PhD; and Patrizio Castelli, MD, FACS

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.